Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How long before seeing results with Lipitor alternatives?What are the risks of using outdated Epinephrine injectors?Are there income restrictions for lipitor's patient program?How is lipitor's impact on the liver different from non statin cholesterol drugs?How does Oriahnn treat uterine fibroids?
See the DrugPatentWatch profile for Stendra
When Will a Generic Version of Stendra Be Available? A generic version of Stendra (avanafil), a medication used to treat erectile dysfunction, has not yet been approved by the FDA. However, as the patent for Stendra approaches its expiration, several generic manufacturers have been developing their own versions of the medication. Patent Expiration and Generic Entry The patent for avanafil, the active ingredient in Stendra, is set to expire in 2029 [1]. After the patent expires, generic manufacturers may introduce their versions of the medication, potentially reducing the cost of treatment for patients. FDA Approval The FDA has approved several generic versions of avanafil, including those from Mylan, Sandoz, and Teva Pharmaceutical [2]. However, the availability of these generic versions may vary depending on the specific product and the pharmacy that dispenses it. Current Market Status As of now, Stendra remains a branded medication, and its price may be higher compared to generic alternatives that become available in the future. However, the availability of generic versions of avanafil may provide patients with more affordable treatment options for erectile dysfunction. Potential Impact on Patients The introduction of generic versions of Stendra may lead to cost savings for patients who rely on this medication for treating erectile dysfunction [3]. However, the generic versions may not be identical to the branded medication in terms of quality, packaging, or formulation. References [1] DrugPatentWatch.com. (n.d.). Avanafil patent data. Retrieved from https://www.drugpatentwatch.com/patents/US-7744652 [2] FDA. (n.d.). Avanafil approval history. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022512s000lbl.pdf [3] American Urological Association. (n.d.). Generic medications and erectile dysfunction. Retrieved from https://www.urologyhealth.org/patient-guide/topics-urologic-care/generic-medications-and-erectile-dysfunction Sources: 1. DrugPatentWatch.com 2. FDA 3. American Urological Association